Brought to you by 
St. Jude buys Advanced Neuromodulation Systems for $1.3bn
20 Oct 2005
Executive Summary
To expand beyond the cardiac arena into the neuromodulation market, St. Jude Medical has agreed to acquire Advanced Neuromodulation Systems (spinal cord stimulation-SCS--devices) in a tender offer of $1.3bn in cash. St. Jude is paying $61.25 for each of ANS's outstanding shares, a 28% premium to the market average.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Implantable Devices
- Radiofrequency Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
St. Jude buys Advanced Neuromodulation Systems for $1.3bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice